$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
PacBio to Present at Upcoming Investor Conferences
04:05pm, Thursday, 11'th Nov 2021
MENLO PARK, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- PacBio announced today that its executives will be speaking at the following investor conferences:
Pacific Biosciences Q3 Revenues Jump 83%, Says Sequel II/IIe Installations At All-Time High
06:42am, Wednesday, 03'rd Nov 2021
Pacific Biosciences of California Inc (NASDAQ: PACB) reported Q3 sales of $34.9 million, beating the consensus of $33.23 million and up 83% Y/Y. The company placed 44 Sequel II or IIe instruments
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q3 2021 Results - Earnings Call Transcript
12:53am, Wednesday, 03'rd Nov 2021
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q3 2021 Results - Earnings Call Transcript
3 Genomics Stocks That Could Soar 60% or Better, According to Wall Street
06:17am, Wednesday, 27'th Oct 2021
The genomic revolution is upon us and these stocks could be great vehicles for investors who want to take advantage of it.
If I Could Only Own 1 Healthcare Stock, This Is What It Would Be
09:25am, Thursday, 21'st Oct 2021
Investing gets simple if you have to put all of your eggs in one basket.
Pacific Biosciences Grants Equity Incentive Award to New Employee
04:05pm, Friday, 24'th Sep 2021
MENLO PARK, Calif., Sept. 24, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality seque
PacBio (PACB) Closes Omniome Buyout, Forays Into San Diego
10:49am, Tuesday, 21'st Sep 2021
PacBio's (PACB) latest acquisition is expected to deliver a differentiated set of products and applications across a wide spectrum of markets.
Pacific Biosciences of California, Inc. to Present at Upcoming Investor Conferences
09:00am, Friday, 03'rd Sep 2021
MENLO PARK, Calif., Sept. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) announced today that its executives will be speaking at the following investor conferences
Are Penny Stocks Worth It? 5 That Deserve Your Attention Now
12:36pm, Thursday, 05'th Aug 2021
Have penny stocks presented some of the biggest opportunities in the stock market? The post Are Penny Stocks Worth It?
PacBio's (PACB) Q2 Earnings Miss Estimates, Revenues Top
12:59pm, Wednesday, 04'th Aug 2021
PacBio (PACB) sees strength in Q2 product revenues, led by robust consumable sales.
Pacific Biosciences: Boom In Genome Sequencing Technology With 35% Upside
07:30am, Wednesday, 04'th Aug 2021
Pacific Biosciences: Boom In Genome Sequencing Technology With 35% Upside
Pacific Biosciences Q2 Earnings Beat Expectations, Higher Operating Costs Widens Quarterly Loss
06:52am, Wednesday, 04'th Aug 2021
Pacific Biosciences of California Inc (NASDAQ: PACB), after the close of the market on Tuesday, reported Q2 sales of $30.6 million, beating the consensus of $29.9 million and up 79% Y/Y. The Compa
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q2 2021 Results - Earnings Call Transcript
11:07pm, Tuesday, 03'rd Aug 2021
Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q2 2021 Results - Earnings Call Transcript
Pacific Biosciences of California (PACB) Reports Q2 Loss, Tops Revenue Estimates
07:04pm, Tuesday, 03'rd Aug 2021
Pacific Biosciences (PACB) delivered earnings and revenue surprises of -5.00% and 0.49%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results
04:05pm, Tuesday, 03'rd Aug 2021
MENLO PARK, Calif., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2021.
Sign In
Buy PACB